Applied DNA Sciences Inc (APDN)

[Shail]

Mike.

One of the things we need to worry about is whether APDN can sustain a price of over $5 for long, to remain listed on Nasdaq.

It may be easy to reverse split and get there but will they have the financials to keep the price above the required norms and meet all other conditions.

What is going to change all of a sudden is what we need to ask. The quarterly results over the last few quarters have shown marginal revenue growth but awful control over expenses. Can they generate a positive bottom line?

Investors on Nasdaq will not tolerate poor performance and it will be terrible if we start drifting lower below $5.

Had this happened after a few quarters of sustained high revenues and lower expenses, it would have been more acceptable.

Having said this, do we common investors have any control over the situation? How much will our vote count? Will someone like Crede object?